• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过喂食免疫显性的髓鞘少突胶质细胞糖蛋白139 - 151肽抑制SJL小鼠复发性实验性自身免疫性脑脊髓炎

Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.

作者信息

Karpus W J, Kennedy K J, Smith W S, Miller S D

机构信息

Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.

出版信息

J Neurosci Res. 1996 Aug 15;45(4):410-23. doi: 10.1002/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4.

DOI:10.1002/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4
PMID:8872901
Abstract

Peripheral antigen-specific tolerance can be induced by feeding protein antigens. The mechanism has been described as either clonal anergy/deletion or induction of antigen-specific regulatory cells that produce transforming growth factor-beta (TGF-beta). These two mechanisms have been linked to the magnitude and frequency of the dose of antigen fed; a single high dose induces anergy/deletion, whereas multiple low doses of antigen induce TGF-beta-secreting regulatory cells. In the present study, we investigated the mechanisms of feeding soluble peptides of proteolipid protein (PLP) for prevention of experimental autoimmune encephalomyelitis (EAE) induced by either intact PLP or the immunodominant PLP139-151 peptide. Feeding PLP139-151 prevented acute and relapsing EAE induced by either PLP139-151 or intact PLP. PLP139-151 feeding induced anergy in the T helper 1 (Th1) population as measured by an inhibition of both proliferation and interferon-gamma (IFN-gamma) production. Interleukin-4 (IL-4) production was increased, but increased TGF-beta production was not observed. Importantly, PLP139-151 feeding induced anergy in peripheral and central nervous system (CNS)-in-filtrating T cells. Feeding of the subdominant PLP epitope (PLP178-191) failed to inhibit EAE induced by PLP139-151; therefore, oral tolerance was not due to induction of bystander suppression. These results demonstrate that both acute and relapsing paralysis in EAE can be prevented by feeding the immunodominant peptide of PLP.

摘要

通过喂食蛋白质抗原来诱导外周抗原特异性耐受。其机制被描述为克隆无能/缺失或诱导产生转化生长因子-β(TGF-β)的抗原特异性调节细胞。这两种机制与喂食抗原剂量的大小和频率有关;单次高剂量诱导无能/缺失,而多次低剂量抗原诱导分泌TGF-β的调节细胞。在本研究中,我们研究了喂食蛋白脂蛋白(PLP)的可溶性肽预防由完整PLP或免疫显性PLP139 - 151肽诱导的实验性自身免疫性脑脊髓炎(EAE)的机制。喂食PLP139 - 151可预防由PLP139 - 151或完整PLP诱导的急性和复发性EAE。通过抑制增殖和干扰素-γ(IFN-γ)产生来测量,喂食PLP139 - 151可诱导辅助性T细胞1(Th1)群体出现无能。白细胞介素-4(IL-4)产生增加,但未观察到TGF-β产生增加。重要的是,喂食PLP139 - 151可诱导外周和中枢神经系统(CNS)浸润性T细胞出现无能。喂食亚显性PLP表位(PLP178 - 191)未能抑制由PLP139 - 151诱导的EAE;因此,口服耐受不是由于旁观者抑制的诱导。这些结果表明,通过喂食PLP的免疫显性肽可预防EAE中的急性和复发性麻痹。

相似文献

1
Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.通过喂食免疫显性的髓鞘少突胶质细胞糖蛋白139 - 151肽抑制SJL小鼠复发性实验性自身免疫性脑脊髓炎
J Neurosci Res. 1996 Aug 15;45(4):410-23. doi: 10.1002/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4.
2
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎复发病理中表位扩展的功能证据。
J Exp Med. 1995 Jul 1;182(1):75-85. doi: 10.1084/jem.182.1.75.
3
Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.用髓磷脂肽偶联脾细胞预防和治疗复发性自身免疫性脑脊髓炎
J Neurosci Res. 1996 Aug 15;45(4):430-8. doi: 10.1002/(SICI)1097-4547(19960815)45:4<430::AID-JNR12>3.0.CO;2-4.
4
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.复发性实验性自身免疫性脑脊髓炎中新出现的自身表位的病理作用及时间表现
J Immunol. 2000 Jan 15;164(2):670-8. doi: 10.4049/jimmunol.164.2.670.
5
Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.诱导抗原特异性耐受用于治疗持续性、复发性自身免疫性脑脊髓炎:口服耐受与外周耐受的比较
J Immunol. 1997 Jul 15;159(2):1036-44.
6
Male SJL mice do not relapse after induction of EAE with PLP 139-151.用髓鞘碱性蛋白139 - 151诱导实验性自身免疫性脑脊髓炎后,雄性SJL小鼠不会复发。
J Neurosci Res. 1996 Sep 15;45(6):680-9. doi: 10.1002/(SICI)1097-4547(19960915)45:6<680::AID-JNR4>3.0.CO;2-4.
7
Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.用脊髓免疫的SJL/J小鼠的淋巴细胞对蛋白脂质蛋白的一种肽产生选择性反应,并传递复发性脱髓鞘实验性自身免疫性脑脊髓炎。
J Immunol. 1991 Jan 1;146(1):101-7.
8
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.髓鞘碱性蛋白T细胞受体转基因小鼠中的口服耐受:自身免疫性脑脊髓炎的抑制及调节性细胞的剂量依赖性诱导
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):388-91. doi: 10.1073/pnas.93.1.388.
9
Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.在小鼠自身免疫性脑脊髓炎的决定簇扩展级联反应发展过程中自主致病性新自身反应性Th1细胞的产生。
J Neurosci Res. 1996 Aug 15;45(4):463-70. doi: 10.1002/(SICI)1097-4547(19960815)45:4<463::AID-JNR16>3.0.CO;2-1.
10
Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.SJL/J小鼠中线性和环状PLP139-151突变肽的免疫反应:游离状态肽与甘露聚糖缀合物的比较
Immunotherapy. 2014;6(6):709-24. doi: 10.2217/imt.14.42.

引用本文的文献

1
ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance.ILDR2-Fc 是一种新型的免疫稳态调节剂和抗原特异性免疫耐受诱导剂。
J Immunol. 2018 Mar 15;200(6):2013-2024. doi: 10.4049/jimmunol.1700326. Epub 2018 Feb 5.
2
Modulating the immune system through nanotechnology.通过纳米技术调节免疫系统。
Semin Immunol. 2017 Dec;34:78-102. doi: 10.1016/j.smim.2017.09.007. Epub 2017 Oct 9.
3
Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.用于在多发性硬化症中诱导免疫耐受的基于纳米和微米的系统。
Hum Vaccin Immunother. 2016 Jul 2;12(7):1886-90. doi: 10.1080/21645515.2016.1138190. Epub 2016 Feb 18.
4
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.口服表达髓鞘抗原合成基因的乳酸乳球菌可减轻大鼠实验性自身免疫性脑脊髓炎
Med Sci Monit. 2015 May 31;21:1587-97. doi: 10.12659/MSM.892764.
5
Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.当前和未来的免疫调节策略,以恢复自身免疫性疾病的耐受性。
Cold Spring Harb Perspect Biol. 2012 Nov 1;4(11):a007542. doi: 10.1101/cshperspect.a007542.
6
Immune modulating peptides for the treatment and suppression of multiple sclerosis.用于治疗和抑制多发性硬化症的免疫调节肽。
Clin Immunol. 2012 Aug;144(2):127-38. doi: 10.1016/j.clim.2012.05.010. Epub 2012 Jun 5.
7
CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.CCL22 通过控制炎症性巨噬细胞的积累和效应功能来调节实验性自身免疫性脑脊髓炎。
J Leukoc Biol. 2011 Jan;89(1):93-104. doi: 10.1189/jlb.0810442. Epub 2010 Oct 12.
8
Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.缺乏CCR6的小鼠无法控制慢性实验性自身免疫性脑脊髓炎。
J Neuroimmunol. 2009 Aug 18;213(1-2):91-9. doi: 10.1016/j.jneuroim.2009.05.011. Epub 2009 Jun 17.
9
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.基于抗原特异性耐受疗法治疗多发性硬化症的前景。
Results Probl Cell Differ. 2010;51:217-35. doi: 10.1007/400_2008_13.
10
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.使用结肠炎提取蛋白进行口服免疫调节治疗克罗恩病:一项I期临床试验的结果
World J Gastroenterol. 2005 May 28;11(20):3105-11. doi: 10.3748/wjg.v11.i20.3105.